US BROKER MOVES: QCOM upgraded at Loop Capital and Wells Fargo; OWL downgraded at Deutsche Bank

UPGRADES

Allurion Technologies (ALUR) upgraded from Neutral to Buy at Chardan; PT USD 3
Booking Holdings (BKNG) upgraded from Equal Weight to Overweight at Morgan Stanley; PT USD 5,500 (from USD 6,150)
Domino’s Pizza (DPZ) upgraded from Neutral to Overweight at JPMorgan; PT USD 450 (from USD 460)
Fox Corp (FOXA) upgraded from Neutral to Buy at Seaport Global; PT USD 64
Freshpet (FRPT) upgraded from Equal Weight to Overweight at Morgan Stanley; PT USD 90 (from USD 71)
Genuine Parts Company (GPC) upgraded from Market Perform to Strong Buy at Raymond James; PT USD 145
PPL Corp (PPL) upgraded from Equal Weight to Overweight at Barclays; PT USD 40 (from USD 37)
Qualcomm (QCOM) upgraded from Hold to Buy at Loop Capital
Qualcomm (QCOM) upgraded from Underweight to Equal Weight at Wells Fargo; PT USD 150 (from USD 135)
Vir Biotechnology (VIR) upgraded from Outperform to Strong Buy at Raymond James; PT USD 19 (from USD 12)

DOWNGRADES

Arcellx (ACLX) downgraded from Buy to Hold at Stifel; PT USD 115 (from USD 127)
Arcellx (ACLX) downgraded from Buy to Neutral at UBS; PT USD 115 (from USD 100)
Afya (AFYA) downgraded from Buy to Neutral at BofA Securities; PT USD 17 (from USD 22)
Backblaze (BLZE) downgraded from Buy to Hold at Craig-Hallum; PT USD 4.50
Boston Properties (BXP) downgraded from Outperform to Neutral at Mizuho; PT USD 62 (from USD 79)
Cable One (CABO) downgraded from Neutral to Underperform at BNP Paribas Exane
Comcast (CMCSA) downgraded from Neutral to Underperform at BNP Paribas Exane
DT Midstream (DTM) downgraded from Buy to Hold at Stifel; PT USD 137 (from USD 121)
Enhabit (EHAB) downgraded from Buy to Neutral at UBS; PT USD 13.80 (from USD 12)
GATX (GATX) downgraded from Buy to Neutral at Citi; PT USD 210 (from USD 197)
Gossamer Bio (GOSS) downgraded from Outperform to Market Perform at Leerink; PT USD 1 (from USD 6)
Gossamer Bio (GOSS) downgraded from Outperform to Neutral at Wedbush; PT USD 1
Gossamer Bio (GOSS) downgraded from Overweight to Underweight at Barclays; PT USD 0.30 (from USD 9)
Kilroy Realty (KRC) downgraded from Neutral to Underperform at Mizuho; PT USD 29 (from USD 37)
Cheniere Energy (LNG) downgraded from Overweight to Equal Weight at Morgan Stanley; PT USD 236 (from USD 258)
Blue Owl Capital (OWL) downgraded from Buy to Hold at Deutsche Bank; PT USD 10 (from USD 15)
Preferred Bank (PFBC) downgraded from Buy to Neutral at Janney; PT USD 100

INITIATIONS

Abivax (ABVX) initiated at Underperform at Wedbush; PT USD 110
Acadia Pharmaceuticals (ACAD) initiated at Outperform at Wolfe Research; PT USD 33
Alkermes (ALKS) initiated at Outperform at Wolfe Research; PT USD 45
Apollo Global Management (APO) initiated at Sector Perform at RBC Capital
Ares Management (ARES) initiated at Outperform at RBC Capital; PT USD 173
Axsome Therapeutics (AXSM) initiated at Outperform at Wolfe Research; PT USD 230
Bloom Energy (BE) initiated at Neutral at Citi; PT USD 162
Blackstone (BX) initiated at Outperform at RBC Capital; PT USD 179
Carlyle Group (CG) initiated at Outperform at RBC Capital; PT USD 67
Centessa Pharmaceuticals (CNTA) initiated at Outperform at Wolfe Research; PT USD 40
Denali Therapeutics (DNLI) initiated at Peerperform at Wolfe Research
Eupraxia Pharmaceuticals (EPRX) initiated at Buy at Bloom Burton; PT USD 14
Eagle Materials (EXP) initiated at Sector Perform at RBC Capital; PT USD 208
Grindr (GRND) initiated at Equal Weight at Morgan Stanley; PT USD 14
KKR (KKR) initiated at Outperform at RBC Capital; PT USD 137
Neurocrine Biosciences (NBIX) initiated at Outperform at Wolfe Research; PT USD 160
Preferred Bank (PFBC) initiated at Neutral at Brean Capital; PT USD 100
Picsart (PICS) initiated at Buy at BofA Securities; PT USD 27
Praxis Precision Medicines (PRAX) initiated at Outperform at Wolfe Research; PT USD 500
uniQure (QURE) initiated at Peerperform at Wolfe Research
SailPoint (SAIL) initiated at Outperform at FBN Securities; PT USD 18
Scinai Immunotherapeutics (SCNX) initiated at Buy at Maxim Group; PT USD 1.50
Sionna Therapeutics (SION) initiated at Market Outperform at Citizens; PT USD 63
Stoke Therapeutics (STOK) initiated at Outperform at Wolfe Research; PT USD 40
TPG (TPG) initiated at Outperform at RBC Capital; PT USD 59
Tyra Biosciences (TYRA) initiated at Overweight at Cantor Fitzgerald
Venture Global (VG) initiated at Underweight at Morgan Stanley; PT USD 8
Cactus (WHD) initiated at Overweight at Piper Sandler; PT USD 73
Xenon Pharmaceuticals (XENE) initiated at Outperform at Wolfe Research; PT USD 60